桂林三金股价小幅上扬 公司回应政策变化与渠道布局

Group 1 - The stock price of Guilin Sanjin reached 15.68 yuan as of August 12, 2025, reflecting a 0.90% increase from the previous trading day [1] - The trading volume on that day was 194 million yuan, with a turnover rate of 2.21%, and the total market capitalization stood at 9.213 billion yuan [1] - Guilin Sanjin operates in the traditional Chinese medicine manufacturing industry, focusing on the research, production, and sales of traditional Chinese medicine and chemical drugs [1] Group 2 - The company's product portfolio includes well-known medications such as Sanjin Pian and Xigua Shuang series, and it is also involved in flu prevention and monoclonal antibody drugs [1] - In response to investor inquiries, the company stated it will closely monitor changes in national policies, enhance risk management, and adjust product structure and marketing strategies as needed [1] - The company is improving its online terminal agreement client layout in the OTC channel and increasing investment in online operations while enhancing brand influence through comprehensive online and offline promotions [1] Group 3 - On August 12, the net outflow of main funds was 1.1881 million yuan, with a cumulative net outflow of 73.1303 million yuan over the past five trading days [1]